AUSSIE BUSINESSES HELP THE KIDS’ CANCER PROJECT MULTIPLY RESEARCH IMPACT
Australian businesses such as QBE Foundation, RAMS, Lorraine Lea, Bromic Group, Bayer, Stylecraft and Apricity have continued their support of the national charity, The Kids’ Cancer Project, by this year committing further funds as part of the charity’s most ambitious fundraising initiative to date – to raise $1.7 million by 31 October through a matched giving appeal.
With 950 Australian children diagnosed with cancer each year and three passing-away every week, funding scientific projects in the fastest way to a cure.
The campaign, which started in August by requesting the support of corporate partners, trusts and foundations and major donors, generated mass community support during Childhood Cancer Awareness Month (September) and is set to continue through to the end of October.
Philanthropic investment goes toward innovation grants to top researchers around Australia through collaboration with like-minded organisations. The Kids’ Cancer Project has committed to funding eight research projects through Cancer Australia’s Priority-driven Collaborative Cancer Research Scheme (PdCCRS) .
Award-winning financial service provider, RAMS has supported The Kids’ Cancer Project since 2018. Jake Bromwich, Managing Director of RAMS said:
“The work at The Kids’ Cancer Project is particularly close to our hearts, and we are proud to join in their mission to support bold scientific research that will improve the treatments of childhood cancers.”
For details on how you can partner with The Kids’ Cancer Project, please contact CEO Owen Finegan firstname.lastname@example.org.
About The Kids’ Cancer Project
The Kids’ Cancer Project is an independent national charity supporting childhood cancer research. Since 1993, thanks to strong community support, they have contributed tens of millions of dollars to scientific studies to help children with many types of cancer.
The Kids’ Cancer Project’s mission is to support bold science that has the greatest chance of clinical success to improve childhood cancer treatments. The vision is to see a one hundred per cent survival rate for children with cancer while eradicating the harmful impacts treatment can bring.